Terms: = Leukemia AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Prognosis
172 results:
1. SRSF12 is a prognostic biomarker involved in immune infiltration in acute myeloid leukemia.
Zhang M; Tan Y; Xie Z; Wang M; Li J
Hematology; 2024 Dec; 29(1):2420301. PubMed ID: 39463061
[TBL] [Abstract] [Full Text] [Related]
2. Targeting Molecular Signaling Pathways and Cytokine Responses to Modulate c-MYC in Acute Myeloid leukemia.
Gu K; May HA; Kang MH
Front Biosci (Schol Ed); 2024 Sep; 16(3):15. PubMed ID: 39344393
[TBL] [Abstract] [Full Text] [Related]
3. Exploring the prognostic value of T follicular helper cell levels in chronic lymphocytic leukemia.
Zhang R; Guo S; Qu J
Sci Rep; 2024 Sep; 14(1):22443. PubMed ID: 39341925
[TBL] [Abstract] [Full Text] [Related]
4. BRG1 promotes progression of B-cell acute lymphoblastic leukemia by disrupting PPP2R1A transcription.
Kang Q; Ma D; Zhao P; Chai X; Huang Y; Gao R; Zhang T; Liu P; Deng B; Feng C; Zhang Y; Lu Y; Li Y; Fang Q; Wang J
Cell Death Dis; 2024 Aug; 15(8):621. PubMed ID: 39187513
[TBL] [Abstract] [Full Text] [Related]
5. NAD metabolism-related genes provide prognostic value and potential therapeutic insights for acute myeloid leukemia.
Cao Y; Shu W; Jin P; Li J; Zhu H; Chen X; Zhu Y; Huang X; Cheng W; Shen Y
Front Immunol; 2024; 15():1417398. PubMed ID: 38966636
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition.
Zhu R; Shirley CM; Chu SH; Li L; Nguyen BH; Seo J; Wu M; Seale T; Duffield AS; Staudt LM; Levis M; Hu Y; Small D
Leukemia; 2024 Jul; 38(7):1581-1591. PubMed ID: 38811818
[TBL] [Abstract] [Full Text] [Related]
7. MLLT6/ATF2 Axis Restrains Breast Cancer Progression by Driving DDIT3/4 Expression.
Yu Q; Zhao J; Yang A; Li X
Mol Cancer Res; 2024 Sep; 22(9):796-811. PubMed ID: 38757913
[TBL] [Abstract] [Full Text] [Related]
8. Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors.
Tecik M; Adan A
Curr Treat Options Oncol; 2024 Jun; 25(6):719-751. PubMed ID: 38696033
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive characterization of immunogenic cell death in acute myeloid leukemia revealing the association with prognosis and tumor immune microenvironment.
Chen Y; Qiu X; Liu R
BMC Med Genomics; 2024 Apr; 17(1):107. PubMed ID: 38671491
[TBL] [Abstract] [Full Text] [Related]
10. UBE2C promotes the proliferation of acute myeloid leukemia cells through pi3k/AKT activation.
Wang L; Zhao S; Wang Y; Liu J; Wang X
BMC Cancer; 2024 Apr; 24(1):497. PubMed ID: 38637730
[TBL] [Abstract] [Full Text] [Related]
11. TET2 mutations contribute to adverse prognosis in acute myeloid leukemia (AML): results from a comprehensive analysis of 502 AML cases and the Beat AML public database.
Pan X; Chang Y; Ruan G; Zhou S; Jiang H; Jiang Q; Huang X; Zhao XS
Clin Exp Med; 2024 Feb; 24(1):35. PubMed ID: 38349460
[TBL] [Abstract] [Full Text] [Related]
12. pi3kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway.
Gu H; Chen C; Hou ZS; He XD; Xie S; Ni J; Qian C; Cheng X; Jiang T; Yang C; Roberts TM; Zheng J; Varner JA; Armstrong SA; Zhao JJ
Blood; 2024 May; 143(19):1965-1979. PubMed ID: 38271660
[TBL] [Abstract] [Full Text] [Related]
13. Inhibition of pi3k-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells.
Şansaçar M; Sağır H; Gencer Akçok EB
Med Oncol; 2023 Dec; 41(1):31. PubMed ID: 38148433
[TBL] [Abstract] [Full Text] [Related]
14. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
15. AXL - a new player in resistance to HER2 blockade.
Adam-Artigues A; Arenas EJ; Arribas J; Prat A; Cejalvo JM
Cancer Treat Rev; 2023 Dec; 121():102639. PubMed ID: 37864955
[TBL] [Abstract] [Full Text] [Related]
16. XBP1 promotes NRAS
Salimi A; Schemionek-Reinders M; Huber M; Vieri M; Patterson JB; Alten J; Brümmendorf TH; Kharabi Masouleh B; Appelmann I
J Cell Mol Med; 2023 Nov; 27(21):3363-3377. PubMed ID: 37753803
[TBL] [Abstract] [Full Text] [Related]
17. Cordycepin improves sensitivity to temozolomide in glioblastoma cells by down-regulating MYC.
Zheng SX; Chen J; Zhuang BB; Zhang Q; Shi SS; Zhang GL
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16055-16067. PubMed ID: 37695389
[TBL] [Abstract] [Full Text] [Related]
18. FBXO21 mediated degradation of p85α regulates proliferation and survival of acute myeloid leukemia.
Dobish KK; Wittorf KJ; Swenson SA; Bean DC; Gavile CM; Woods NT; Ghosal G; Hyde RK; Buckley SM
Leukemia; 2023 Nov; 37(11):2197-2208. PubMed ID: 37689825
[TBL] [Abstract] [Full Text] [Related]
19. Bcl-2 inhibition combined with PPARα activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemia.
Xie C; Zhou H; Qin D; Zheng H; Tang Y; Li W; Zhou J; Liu L; Yu X; Duan H; Zhou Y; Li Z; Fang Z; Luo Y; Carter BZ; Xu B; Zha J
Cell Death Dis; 2023 Aug; 14(8):573. PubMed ID: 37644011
[TBL] [Abstract] [Full Text] [Related]
20. Expression and Alteration Value of Long Noncoding RNA AB073614 and FER1L4 in Patients with Acute Myeloid leukemia (AML).
Ganji A; Khosravi M; Mosayebi G; Gholami M; Ghazavi A; Keshavarzian N; Sayyadi M
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2271-2277. PubMed ID: 37505756
[TBL] [Abstract] [Full Text] [Related]
[Next]